Antioxidant N-acetylcysteine attenuates hepatocarcinogenesis by inhibiting ROS/ER stress in TLR2 deficient mouse

PLoS One. 2013 Oct 2;8(10):e74130. doi: 10.1371/journal.pone.0074130. eCollection 2013.

Abstract

Hepatocellular carcinoma (HCC) remains one of the most deadly solid tumor malignancies worldwide. We recently find that the loss of toll-like receptor 2 (TLR2) activities promotes the diethylnitrosamine (DEN) induced hepatocellular carcinogenesis and tumor progression, which associates with an abundant accumulation of reactive oxygen species (ROS) and endoplasmic reticulum (ER) stress. This finding suggests that the ROS/ER stress plays a role in TLR2 modulated carcinogenesis of HCC. To investigate the mechanism of TLR2 activity defending against hepatocarcinogenesis, the TLR2-deficient mice were treated with or without antioxidant N-acetylcysteine (NAC) before DEN administration. We found that pretreatment of these animals with NAC attenuated carcinogenesis and progression of HCC in the TLR2-deficient mice, declined ROS/ER stress, and alleviated the unfold protein response and inflammatory response in TLR2-deficient liver tissue. Moreover, the NAC treatment significantly reduced the enhanced aggregation of p62 and Mallory-Denk bodies in the DEN-induced HCC liver tissue, suggesting that NAC treatment improves the suppressive autophagic flux in the TLR2-deficient liver. These findings indicate that TLR2 activity defends against hepatocarcinogenesis through diminishing the accumulation of ROS and alleviating ER stress and unfold protein response mediated inflammatory response in the liver.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcysteine / pharmacology*
  • Animals
  • Antioxidants / pharmacology*
  • Carcinogenesis / drug effects*
  • Carcinoma, Hepatocellular / metabolism
  • Carcinoma, Hepatocellular / pathology
  • Cell Line
  • Diethylnitrosamine / adverse effects
  • Disease Progression
  • Endoplasmic Reticulum Stress / drug effects*
  • Liver Neoplasms / metabolism
  • Liver Neoplasms / pathology*
  • Male
  • Mice
  • Reactive Oxygen Species / metabolism*
  • Signal Transduction / drug effects
  • Toll-Like Receptor 2 / deficiency*

Substances

  • Antioxidants
  • Reactive Oxygen Species
  • Tlr2 protein, mouse
  • Toll-Like Receptor 2
  • Diethylnitrosamine
  • Acetylcysteine

Grants and funding

This work was supported by grants from the National Natural Science Foundation of China (30973557), the Major Program of the National Natural Science Foundation (81030056), the International Corporation Project supported by the Ministry of Science and Technology (2010DFB32900), and the Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT, No. IRT1007). Dr. Fang Hua is supported by a grant from the National Natural Science Foundation of China (81101595). Dr. Heng Lin is supported by a grant from the Basic Research Program of the Institute of Materia Medica (2013CHX17). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.